Cargando…
Diabetic Retinopathy
Diabetic retinopathy is the most common microvascular complication of diabetes. It remains a major cause of new-onset visual loss in the United States and other industrialized nations. In Diabetic Retinopathy, Elia Duh and a panel of internationally recognized experts comprehensively assess the curr...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2008.
|
| Edición: | 1st ed. 2008. |
| Colección: | Contemporary Diabetes,
|
| Temas: | |
| Acceso en línea: | Texto Completo |
Tabla de Contenidos:
- Clinical Aspects of Diabetic Retinopathy
- Nonproliferative Diabetic Retinopathy
- Proliferative Diabetic Retinopathy
- The Epidemiology of Diabetic Retinopathy
- Diagnostic Modalities in Diabetic Retinopathy
- Pathophysiology / Basic Research
- In Vivo Models of Diabetic Retinopathy
- The Polyol Pathway and Diabetic Retinopathy
- The Role of Advanced Glycation in Diabetic Retinopathy
- The Role of Protein Kinase C in Diabetic Retinopathy
- Oxidative Stress in Diabetic Retinopathy
- Pericyte Loss in the Diabetic Retina
- Capillary Dropout in Diabetic Retinopathy
- Neuroglial Dysfunction in Diabetic Retinopathy
- The Role of Inflammation in the Pathophysiology of Diabetic Retinopathy
- Vascular Permeability in Diabetic Retinopathy
- Retinal Neovascularization and the Role of VEGF
- Beyond VEGF - Other Factors Important in Retinal Neovascularization: Potential Targets in Proliferative Diabetic Retinopathy
- Emerging Treatments and Concepts in Diabetic Retinopathy
- Anti-VEGF Therapy as an Emerging Treatment for Diabetic Retinopathy
- Clinical Trials in Protein Kinase C-? Inhibition in Diabetic Retinopathy
- The Role of Intravitreal Steroids in the Management of Diabetic Retinopathy
- Antagonism of the Growth Hormone Axis as a Therapeutic Strategy for Diabetic Retinopathy
- Diabetic Retinopathy and Systemic Complications.